Failure of a 1-day high-dose quadruple therapy for cure of Helicobacter pylori infection

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 2, 1999, Pages 173-177

  Wermeille, J ^a   Cunningham, M ^a   Armenian, B ^a   Zelger, G ^a   Buri, P ^b   Merki, H ^c   Hadengue, A ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA   (Switzerland)

^c Clinic Beau Site   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ANTIBIOTIC THERAPY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 0033057173     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00447.x     Document Type: Article

References (32)

1. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; i: 1311-15.
2. Hentschel E, Brandstätter G, Dragosics B, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993; 328: 308-12.
3. Graham DY, Lew GM, Evans DG, Evans DJ, Klein PD. Effect of triple therapy (antibiotics plus bismuth) on duodenal ulcer healing. Ann Intern Med 1991; 115: 266-9.
4. Valle J, Seppälä K, Sipponen P, Kosunen T. Disappearance of gastritis after eradication of Helicobacter pylori: a morphometric study. Scand J Gastroenterol 1991; 26: 1057-65.
5. Dixon MF. Campylobacter pylori and chronic gastritis. In: Rathbone BI, Heatley RV, eds. Helicobacter pylori and Gastroduodenal Disease. London: Blackwell Scientific, 1989: 106-16.
6. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. J Am Med Assoc 1994; 272: 65-9.
7. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomized controlled trial. Lancet 1994; 343: 508-10.
8. Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995; 332: 139-42.
9. Lind T, Veldhuyzen van Zanten SJO, Unge P, et al. Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I study. Helicobacter 1996; 1: 138-44.
10. Wermeille J, Zelger G, Cunningham M. The eradication treatments of Helicobacter pylori. Pharm World Sci 1998; 20: 1-17.
11. Graham DY, Lew GM, Malaty HM, et al. Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology 1992; 102: 493-6.
12. Cutler AF, Schubert TT. Patient factors affecting Helicobacter pylori eradication with triple therapy. Am J Gastroenterol 1993; 88: 505-9.
13. Tucci A, Corinaldesi R, Stanghellini V, et al. One-day therapy for treatment of Helicobacter pylori infection. Dig Dis Sci 1993; 38: 1670-3.
14. De Boer WA, Van Etten RJXM, Schade RWB, et al. One-day intensified lansoprazole-quadruple therapy for cure of Helicobacter pylori. Aliment Pharmacol Ther 1997; 11: 109-12.
15. Takats A, Racz I, Boga B, Gero G. Efficacy of a one-day-triple-therapy with potentialisation of omeprazole for eradication of Helicobacter pylori. Am J Gastroenterol 1994; 89: 1399 (Abstract).
16. Dobrucali A, Tuncer M, Bal K, et al. One-day, high dose combined therapy of Helicobacter pylori infection. Gut 1995; 37(Suppl. 2): A240(Abstract).
17. Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ. Impact of metronidazole resistance on the eradication of Helicobacter pylori. Scand J Infect Dis 1994; 26: 321-7.
18. Sieber CC, Frei R, Beglinger C, et al. Helicobacter pylori resistance against metronidazole in Switzerland: implication for eradication therapy? Schweiz Med Wochenschr 1994; 124: 1381-4.
19. Cayla R, Zerbib F, Talbi P, Mégraud F, Lamouliatte H. Pre- and post-treatment clarithromycin resistance of Helicobacter pylori strains: a key factor of treatment failure. Gut 1995; 37(Suppl. 1): A55(Abstract).
20. Xia HX, Buckley M, Hyde D, Keane CT, O'Morain CA. Effect of antibiotic-resistance on clarithromycin-combined triple therapy for Helicobacter pylori. Gut 1995; 37(Suppl. 1): A55(Abstract).
21. Heuss LT, Sieber CC, Frei R, Stadler GA, Beglinger C. Resistenzentwicklung von H. pylori gegen amoxicillin, metronidazol und clarithromycin in der schweiz 1992-96. Schweiz Med Wochenschr 1997; 127(Suppl. 93): A128(Abstract).
22. Graham DY. Clarithromycin for treatment of Helicobacter pylori infections. Eur J Gastroenterol Hepatol 1995; 7(Suppl.): S55-8.
23. Rokkas T, Mavrogeorgis A, Liatsos C, Rallis E, Kalogeropoulos N. Optimal dose of omeprazole in combination with amoxicillin in eradicating Helicobacter pylori and preventing relapses in duodenal ulcer patients. Hepatogastroenterology (Greece) 1995; 42: 842-6.
24. Labenz J. Helicobacter pylori therapy with omeprazole and clarithromycin: current status. Leber Magen Darm 1994; 24: 203-9.
25. Gustavson LE, Kaiser JF, Edmonds AL, Locke CS, Debartolo ML, Schneck DW. Effect of omeprazole on concentrations of clarithromycin in plasma and gastric tissue at steady state. Antimicrob Agents Chemother 1995; 39: 2078-83.
26. Goddard AF, Jessa MJ, Barrett DA, et al. Effect of omeprazole on the distribution of metronidazole, amoxicillin and clarithromycin in human gastric juice. Gastroenterology 1996; 111: 358-67.
27. Marshall BJ, Warren JR, Graham JF, Langton SR, Goodwin CS, Blincow ED. Rapid urease test in the management of Campylobacter pyloridis-associated gastritis. Am J Gastroenterol 1987 82: 200-10.
28. Mégraud F. Advantage and disadvantage of current diagnostic tests for the detection of Helicobacter pylori. Scand J Gastroenterol 1996; 31(Suppl. 215): 57-62.
29. Soulé JC, Fléjou JF, Rousseau M, Sallerin V, Mégraud F. Comparison of 4 diagnostic methods for Helicobacter pylori infection: a multicenter study using centralised facilities. Gastroenterology 1995; 108: A224(Abstract).
30. Lawanga SK, Lemeshow S. Sample Size Determination in Health Studies. Geneva: WHO (World Health Organization), 1991.
31. Bell GD, Powell K, Burridge SM, et al. Experience with triple anti-Helicobacter pylori eradication therapy: side effects and the importance of testing the pre-treatment bacterial isolate for metronidazole resisitance. Aliment Pharmacol Ther 1992; 6: 427-35.
32. Labenz J, Leverkus F, Börsch G. Omeprazole plus amoxicillin for cure of Helicobacter pylori infection: factors influencing the treatment success. Scand J Gastroenterol 1994; 29: 1070-5.